The level of evidence grades (A-D) are provided for the most significant recommendations and are defined at the end of the "Major Recommendations" field.

Health Assessment Screening, History, and Counseling

Ages 18 to 49 Years

One health maintenance exam (HME) every 1 to 5 years according to risk status [D]. Each HME should include:

• Height, weight, and body mass index (BMI)
• Risk Evaluation & Counseling (nutrition, obesity, physical activity, dental health, tobacco use [A], immunizations, human immunodeficiency virus (HIV) prevention [B], sexually transmitted infections prevention [B] and sexual health, sexual abuse, preconception counseling for all women of reproductive age [B], polypharmacy including over-the-counter and herbal preparations when appropriate, sun exposure)
• Safety (domestic violence, seat belts [B], helmets, firearms, smoke and carbon monoxide detectors)
• Behavioral Assessment (depression, suicide threats, alcohol/drug use, anxiety, stress reduction, coping skills)

Blood Pressure Monitoring [A]

Ages 18 to 49 Years

At every office visit and, at minimum, every 2 years. If blood pressure (BP) 120-139/80-89 or higher and/or presence of risk factors, more frequent monitoring is recommended.

Cholesterol and Lipid Screening [B]

Ages 18 to 49 Years

Measure a complete fasting lipoprotein profile (i.e., total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C]) in men 35 years and older and women 45 years and older without other risk factors. Screen younger adults for lipid disorders if other risk factors for coronary heart disease (CHD) (i.e., diabetes, family history of cardiovascular disease before age 50 in male relatives or age 60 in female relatives), multiple CHD risk factors (e.g., tobacco use, hypertension). Once screening begins, repeat every 5 years for low risk adults if initial test normal; consider more frequent screening in individuals at increased risk.

Diabetes Mellitus Screening [D]

Ages 18 to 39 Years

Screening may be indicated in patients with risk factors for diabetes (e.g., obesity, family history, high-risk ethnic groups [African Americans, Native Americans, Hispanics and Pacific Islanders], previously identified impaired fasting plasma glucose [FPG] or impaired glucose tolerance; history of gestational diabetes, hypertension, HDL-C < 35 mg/dL and/or triglyceride > 250 mg/dL, polycystic ovarian disease, or history of vascular disease)

Ages 40 to 49 Years

FPG every 3 years (especially if BMI >25) starting at age 45.

Colorectal Cancer Screening [B] for Average Risk Adults

Ages 18 to 49 Years

No requirement unless high risk (e.g., family history, history of colorectal polyps, chronic inflammatory bowel disease)

Glaucoma Screening [C]

Ages 18 to 39 Years

No requirement unless high risk (e.g., increased intraocular pressure, family history, African Americans, people who have diabetes, myopia, regular/long-term steroid use, previous eye injury)

Ages 40 to 49 Years

Begin screening high risk patients annually at age 45

Cervical Cancer Screening [A] Pap Smear

Ages 18 to 49 Years

At least every 3 years, more frequently if high risk (i.e., history of abnormal Pap results, sexually transmitted diseases or HIV; sexual activity before age 18 or multiple partners; vaginal spotting or bleeding between periods, after intercourse or after menopause; tobacco use). (Consider discontinuation for patients with surgical removal of cervix for benign conditions).

Chlamydia Screening [B]

Ages 18 to 49 Years

Recommended for all sexually active women age 24 and younger, and sexually active women age 25 and older if high risk (i.e., new or multiple sexual partners, history of sexually transmitted diseases, not using condoms consistently or correctly).

Mammography with or without Clinical Breast Examination [C]

Ages 18 to 39 Years

No requirement, unless high risk

Ages 40 to 49 Years

Every 1 to 2 years

Immunizations

The type of evidence is provided for the most significant recommendations (see "Major Recommendations" field).

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.